DrugPatentWatch Database Preview

Synthon Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SYNTHON PHARMS, and what generic alternatives to SYNTHON PHARMS drugs are available?

SYNTHON PHARMS has twelve approved drugs.

There is one US patent protecting SYNTHON PHARMS drugs. There are three tentative approvals on SYNTHON PHARMS drugs.

There are four patent family members on SYNTHON PHARMS drugs in four countries and thirty-four supplementary protection certificates in ten countries.

Summary for Synthon Pharms

International Patents:	4
US Patents:	1
Tradenames:	10
Ingredients:	10
NDAs:	12

Drugs and US Patents for Synthon Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Synthon Pharms	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET;ORAL	077540-001	Apr 23, 2007		DISCN	No	No
Synthon Pharms	RISPERIDONE	risperidone	TABLET;ORAL	078187-001	Oct 22, 2009		DISCN	No	No
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	077080-001	Jun 27, 2007		DISCN	No	No
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	077080-002	Jun 27, 2007		DISCN	No	No
Synthon Pharms	SIMVASTATIN	simvastatin	TABLET, ORALLY DISINTEGRATING;ORAL	021961-004	Oct 9, 2007		DISCN	No	No

Premature patent expirations for SYNTHON PHARMS

Expiration due to failure to pay maintenance fee

Patent Number	Expiration Date

International Patents for Synthon Pharms Drugs

Country	Patent Number	Estimated Expiration
Argentina	037565
World Intellectual Property Organization (WIPO)	03043635
European Patent Office	1448197
Australia	2002343257

Supplementary Protection Certificates for Synthon Pharms Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2236132	122015000006	Germany		PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
2236132	C300714	Netherlands		PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
0720599	26/2005	Austria		PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402
0503785	C300375	Netherlands		PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819
0296749	97C0023	France		PRODUCT NAME: ANASTROZOLE, EVENTUELLEMENT SOUS LA FORME D UN SEL D ADDITION ACCEPTABLE EN MEDECINE PHARMACEUTIQUE; NAT REG. NO/DATE: NL 21126 19961227; FIRST REG.: 12619/0106 19950811

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Synthon Pharms